Evolus (EOLS) Other Operating Expenses (2017 - 2026)
Evolus (EOLS) posted Other Operating Expenses of $14000.0 for Q1 2026, down 99.69% on a QoQ basis from $4.5 million in Q4 2025, and up 100.65% year-over-year from $6977.3 in Q1 2025.
Evolus (EOLS) Other Operating Expenses (2017 - 2026) Analysis & Trends
Evolus' Other Operating Expenses history runs 10 years deep, the most recent figure standing at $14000.0 for Q1 2026.
- Quarterly Other Operating Expenses rose 100.65% year-over-year to $14000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $8.5 million (up 210.29% YoY) and the FY2025 annual result came in at $6.4 million, up 188.92% from the prior year.
- Other Operating Expenses was $14000.0 for Q1 2026 at Evolus, down from $4.5 million in the prior quarter.
- Across five years, Other Operating Expenses topped out at $4.5 million in Q4 2025 and bottomed at -$2.4 million in Q3 2024.
- A 5-year average of -$634882.4 and a median of -$1.6 million in 2024 frame the typical range for Other Operating Expenses.
- Annual changes were most pronounced in 2024 — Other Operating Expenses slumped 278.86% — and 2025, when it soared 388.24%.
- Evolus' Other Operating Expenses stood at -$1.8 million in 2022, then surged by 148.37% to $875000.0 in 2023, then slumped by 278.86% to -$1.6 million in 2024, then surged by 388.24% to $4.5 million in 2025, then tumbled by 99.69% to $14000.0 in 2026.
- Business Quant data shows EOLS's Other Operating Expenses at $14000.0 in Q1 2026, $4.5 million in Q4 2025, and $107000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Evolus | 390.47 Mn | 340.68 Mn | 48.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 14,000.00 |
| Dec 31, 2025 | 4.51 Mn |
| Sep 30, 2025 | 107,000.00 |
| Jun 30, 2025 | 3.91 Mn |
| Mar 31, 2025 | -2.15 Mn |
| Dec 31, 2024 | -1.57 Mn |
| Sep 30, 2024 | -2.43 Mn |
| Jun 30, 2024 | -1.61 Mn |
| Mar 31, 2024 | -1.58 Mn |
| Dec 31, 2023 | 875,000.00 |
| Sep 30, 2023 | -1.80 Mn |
| Jun 30, 2023 | -1.68 Mn |
| Mar 31, 2023 | -1.65 Mn |
| Dec 31, 2022 | -1.81 Mn |
| Sep 30, 2022 | -1.22 Mn |
| Jun 30, 2022 | -1.41 Mn |
| Mar 31, 2022 | -1.32 Mn |
| Dec 31, 2021 | 29.55 Mn |
| Jun 30, 2021 | -1.38 Mn |
| Mar 31, 2021 | 25.50 Mn |